Troxipide

Troxipide is an orally active defensive factor-enhancing therapeutic agent for gastritis and gastric ulcer (GU) . Troxipide is a non-antisecretory gastro protective agent with antiulcer, anti-inflammatory and mucus-secreting properties[1][2].

Product Specifications

CAS Number

[30751-05-4]

UNSPSC

12352005

Hazard Statement

H315, H319

Target

Others

Type

Reference compound

Related Pathways

Others

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/Troxipide.html

Purity

99.62

Solubility

DMSO : 9.09 mg/mL (ultrasonic) |H2O : 1 mg/mL (ultrasonic; warming; heat to 80°C)

Smiles

O=C(NC1CNCCC1)C2=CC(OC)=C(OC)C(OC)=C2

Molecular Formula

C15H22N2O4

Molecular Weight

294.35

Precautions

H315, H319

References & Citations

[1]Hongbin Guo, et al. Metabolites profiling and pharmacokinetics of troxipide and its pharmacodynamics in rats with gastric ulcer. Sci Rep. 2020 Aug 12;10 (1) :13619.|[2]K Kusugami, et al. Troxipide, a novel antiulcer compound, has inhibitory effects on human neutrophil migration and activation induced by various stimulants. Dig Liver Dis. 2000 May;32 (4) :305-11.